ARVINAS, INC. — Director's Dealing 2020

Mar 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2020-02-27

Reporting Person: Peck Ronald (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-27	Stock Option (right to buy)	$47.38	A	75000	Acquired	2030-02-26	Common Stock (75000)	Direct

Footnotes

F1: This option award was granted on February 27, 2020. 1/4 of the shares underlying the award shall vest on February 27, 2021, with the remainder of the shares vesting in equal monthly installments following February 27, 2021 through February 27, 2024.